MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Predictors of Cognitive Impairments and Mood Disorders after Subthalamic Deep Brain Stimulation in Patients with Parkinson’s Disease

O. Alenikova, M. Dymkovskaya, A. Bunyak, E. Mykitchuk, S. Kantsevich (Minsk, Belarus)

Meeting: 2025 International Congress

Keywords: Cognitive dysfunction, Depression, Subthalamic nucleus(SIN)

Category: Parkinson's Disease: Surgical Therapy

Objective: We aimed to determine the predictors of cognitive decline and mood disorders after STN-DBS in PD.

Background: Cognitive impairment and mood disorders are the most common complications after subthalamic nucleus stimulation (STN-DBS) surgery. These symptoms may be related to a reduction in the levodopa dosage or caused by the DBS itself. The STN DBS effects on cognition and mood, including depression and anxiety, are mediated by alteration activity in mesocortical and mesolimbic pathways, as well as between cortical areas and the basal ganglia.

Method: A total of 22 PDpatients aged 45-60 years were examined. MRI voxel-based morphometry and tractography was applied before surgery. Neuropsychological testing was performed to identify 1) anxiety (Montgomery-Åsberg Depression Rating Scale and depression severity (Generalised anxiety disorder assessment GAD-7), 2) frontal-striatal, posterior cortical, and mixed subtypes of mild cognitive impairment (MCI) preoperatively and over the next 3–5 years after STN-DBS surgery in PD patients. Neuroimaging included MRI voxel-based morphometry and tractography.

Results: Within 3-5 years after STN-DBS surgery, 13 patients developed moderate or severe depression, and 12 progressed to severe anxiety. These patients had a more pronounced decrease in volume in the amygdala, hippocampus, orbitofrontal cortex, anterior cingulate and dorsolateral prefrontal cortex. In addition, PD patients with depression and anxiety progression showed a significant reduction in tract density connecting the amygdala with the lateral orbitofrontal cortex and dorsolateral prefrontal cortex.

In a retrospective analysis, PD patients with pre-surgical frontostriatal or mixed MCI had greater cognitive decline in subsequent years compared with the patients with posterior cortical MCI. These patients, along with a decrease in the density of the tracts connecting the frontal cortex with the caudate nucleus and putamen, had a more pronounced decrease in the volume of the orbitofrontal, ventromedial prefrontal cortex and hippocampus.

Conclusion: It is important to be able to predict which patients are most likely to develop emotional and cognitive impairment after STN-DBS surgery. To select candidates for STN-DBS surgery, it is necessary to take into account MRI morphometry and tractography data, as well as MCI subtypes prior to surgery.

To cite this abstract in AMA style:

O. Alenikova, M. Dymkovskaya, A. Bunyak, E. Mykitchuk, S. Kantsevich. Predictors of Cognitive Impairments and Mood Disorders after Subthalamic Deep Brain Stimulation in Patients with Parkinson’s Disease [abstract]. Mov Disord. 2025; 40 (suppl 1). https://www.mdsabstracts.org/abstract/predictors-of-cognitive-impairments-and-mood-disorders-after-subthalamic-deep-brain-stimulation-in-patients-with-parkinsons-disease/. Accessed October 5, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2025 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/predictors-of-cognitive-impairments-and-mood-disorders-after-subthalamic-deep-brain-stimulation-in-patients-with-parkinsons-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • AI-Powered Detection of Freezing of Gait Using Wearable Sensor Data in Patients with Parkinson’s Disease
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Insulin dependent diabetes and hand tremor
  • Improvement in hand tremor following carpal tunnel release surgery
  • Impact of expiratory muscle strength training (EMST) on phonatory performance in Parkinson's patients
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley